Takayuki Takahama

Kindai University

Higashiosaka, Osaka

Japan

SCHOLARLY PAPERS

1

DOWNLOADS

20

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase II, Open Label, Single-Arm Study on the Efficacy of Cabozantinib in Patients with Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring Met Exon 14 Alterations Who Developed Acquired Resistance to Tepotinib or Capmatinib (CAPTURE Trial)

Number of pages: 11 Posted: 29 Aug 2024
Kindai University, Nara Medical University, Kyushu University - Kyushu University Hospital, Sendai Kousei Hospital - Department of Pulmonary Medicine, Juntendo University, affiliation not provided to SSRN, Niigata Cancer Center Hospital, National Hospital Organization Nagoya Medical Center, Kindai University, Hiroshima University - Hiroshima University Hospital, Ehime University and Yamaguchi University
Downloads 20 (1,157,925)

Abstract:

Loading...

Lung cancer, MET, acquired resistance, cabozantinib, clinical trial